OXELUMAB
UNII 67GFR7JCMN

Substance Identification & Data

This profile provides standardized clinical and technical data for Oxelumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 67GFR7JCMN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1186098-83-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
67GFR7JCMN
CAS Registry Number
1186098-83-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OXELUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9320
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
YY-13
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oxelumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OXELUMAB

Common Names & Synonyms

HUMAB OX 40L
OXELUMAB [INN]
OXELUMAB [USAN]
OXELUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN, ANTI-(HUMAN ANTIGEN OX-40 LIGAND) (HUMAN MONOCLONAL .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER

Technical Codes

HUMAB OX40L
HUMAB OX-40L
R4930
R-4930
R-4930 HUMAB OX40L
RO4989991
RO-4989991
RO-49-89991